Of course, more investigations are needed to confirm the correlation of the described pathways with the TREM2-related loss of functions disease, including frontotemporal dementia, but our approach has aptly demonstrated that it can contribute to managing NHD and other FTD diseases in the future. The gene discussed is TREM2; the disease is Nasu-Hakola disease.